StemCells Company Profile (NASDAQ:STEM)

Analyst Ratings

Consensus Ratings for StemCells (NASDAQ:STEM) (?)
Ratings Breakdown: 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $17.06 (4,637.50% upside)

Analysts' Ratings History for StemCells (NASDAQ:STEM)
Show:
DateFirmActionRatingPrice TargetActions
6/24/2016S&P Equity ResearchLower Price Target$0.39 -> $0.33View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016Maxim GroupDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Rodman & RenshawReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Chardan CapitalReiterated RatingBuy$12.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2015HC WainwrightLower Price TargetBuy$25.20 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2015Royal Bank Of CanadaReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015Cantor FitzgeraldReiterated RatingBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Ascendiant Capital MarketsReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for StemCells (NASDAQ:STEM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/6/2016        
3/23/2016Q4($0.09)($0.07)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2015($0.10)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.09)($0.09)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q1($0.14)($0.11)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/16/2015Q4($0.12)($0.14)$220.00 million$883.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014($0.13)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014Q2($0.14)($0.22)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/14/2014Q1($0.12)($0.14)$0.24 million$0.34 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2014Q4($0.13)($0.13)$0.22 million$0.31 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q113($0.13)($0.17)$0.29 million$0.28 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/21/2013Q412($0.14)($0.07)$0.31 million$0.21 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for StemCells (NASDAQ:STEM)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for StemCells (NASDAQ:STEM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for StemCells (NASDAQ:STEM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/29/2015Kenneth Blair StrattonGeneral CounselSell104,549$0.45$47,047.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for StemCells (NASDAQ:STEM)
DateHeadline
07/23/16 10:25 AMEquity Roundup: Stock Performance Focus on StemCells, Inc. (NASDAQ:STEM) - Press Telegraph
07/21/16 09:25 AMHC Stocks in Front Line: Johnson & Johnson (NYSE:JNJ), StemCells Inc (NASDAQ:STEM) - share market updates (press release)
07/20/16 07:35 PMStemCells, Inc. (NASDAQ:STEM): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/20/16 09:31 AMCanadian Plastics Industry Association Announces 2016/17 Board of Directors
07/19/16 03:48 PMSTEMCELLS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra -
07/19/16 07:35 AMStemCells, Inc. (NASDAQ:STEM) Wall Street Analyst Recommendation Outlook - TGP
07/19/16 07:35 AMAfter Forming Wedge Down Chart Pattern, Is StemCells Inc's Near-Term Analysis Negative? - Press Telegraph
07/19/16 07:35 AMHC Stocks Watchful: StemCells Inc (NASDAQ:STEM), Mylan NV (NASDAQ:MYL) - share market updates (press release)
07/16/16 05:58 PMStemCells, Inc. (STEM) Updated Price Targets - FTSE News
07/12/16 06:51 PMWhat's Hot Today: Newmont Mining Corporation (NYSE:NEM), StemCells Inc. (NASDAQ:STEM), Gilead Sciences Inc ... - KC Register
07/12/16 06:51 PMStrong Sell Calls For StemCells, Inc. (NASDAQ:STEM) At 0 - Investor Newswire
07/12/16 06:51 PMNext Weeks Broker Price Targets For StemCells, Inc. (STEM) - Fiscal Standard
07/12/16 06:51 PMHC Stocks Updates: Idera Pharmaceuticals Inc (NASDAQ:IDRA), StemCells Inc (NASDAQ:STEM) - share market updates (press release)
07/07/16 06:41 PMRegenerative Medicines Market Worth 49.41 Billion USD by 2021
07/07/16 09:21 AMMajor embryonic stem cell biotech company going out of business
07/06/16 07:00 PMWhat's StemCells Inc Downside After Forming Wedge Down Pattern? - Engelwood Daily
07/05/16 10:28 AMHC Stocks Judgment: St. Jude Medical, Inc. (NYSE:STJ), StemCells Inc (NASDAQ:STEM) - share market updates (press release)
07/03/16 05:51 PMHow Analysts Rated StemCells Inc (NASDAQ:STEM) Last Week? - Press Telegraph
07/01/16 04:07 PMSTEMCELLS INC Files SEC form 8-K, Regulation FD Disclosure -
07/01/16 09:19 AMHC Stocks Indications: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), StemCells Inc (NASDAQ:STEM) - share market updates (press release)
07/01/16 09:19 AMHC Stocks Updates: StemCells Inc (NASDAQ:STEM), Horizon Pharma PLC (NASDAQ:HZNP) - share market updates (press release)
06/29/16 06:30 PMGlobal Canavan Disease Therapeutics Pipeline Report 2016 Featuring StemCells & Turing Pharmaceuticals - Research and Markets
06/28/16 06:29 PMCovering the Bases on StemCells, Inc. (NASDAQ:STEM): Where is the Stock Going? - Press Telegraph
06/28/16 06:29 PMHC Stocks Outlines: StemCells Inc (NASDAQ:STEM), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - share market updates (press release)
06/27/16 06:29 PMWhy Need to Watch: Minerals Technologies Inc. (NYSE:MTX), StemCells Inc (NASDAQ:STEM), Galena Biopharma Inc ... - KC Register
06/27/16 06:29 PMStrong Sell Calls Recommendations For StemCells, Inc. (NASDAQ:STEM) At 0 - Investor Newswire
06/27/16 10:00 AMHow Many StemCells Inc (NASDAQ:STEM)'s Analysts Are Bearish? - Engelwood Daily
06/27/16 10:00 AMNews Buzz: American Airlines (NASDAQ:AAL), StemCells Inc. (NASDAQ:STEM), Nokia (NYSE:NOK), The Walt Disney ... - KC Register
06/27/16 10:00 AMStemCells, Inc. (STEM) Broker Price Targets For The Coming Week - Fiscal Standard
06/27/16 10:00 AMHC Stocks in Hub: StemCells Inc (NASDAQ:STEM), Celgene Corporation (NASDAQ:CELG) - share market updates (press release)
06/25/16 05:59 PMFriday's Highlights at Noon: StemCells Inc (STEM), MannKind Corporation (MNKD), Threshold Pharmaceuticals (THLD ... - Analyst Ratings
06/23/16 07:18 PMHC Stocks in Hub: Johnson & Johnson (NYSE:JNJ), StemCells Inc (NASDAQ:STEM) - share market updates (press release)
06/23/16 09:11 AMSpinal Cord Injury Pipeline Market 2016 Global Forecast Analysis Research
06/22/16 09:59 AMTuesday's Mid-Day Stock Update: IsoRay Inc (ISR), StemCells Inc (STEM), Lpath Inc (LPTN), Threshold ... - Analyst Ratings
06/21/16 06:07 PMWhat Analyst's have to say about StemCells Inc (NASDAQ:STEM) - iStreetWire
06/21/16 06:07 PMStrong Buy Calls Count For StemCells, Inc. (NASDAQ:STEM) At 0 - Investor Newswire
06/20/16 06:11 PMU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.73%
06/19/16 10:15 AMForm 4 STEMCELLS INC For: Jun 17 Filed by: Stratton Kenneth Blair
06/18/16 10:31 AMFriday's Mid-Day Stock Update: StemCells Inc (STEM), Sunshine Heart Inc (SSH), Advanced Micro Devices (AMD ... - Analyst Ratings
06/17/16 06:19 PMRecently Issued Stock Ratings For StemCells, Inc. (STEM) - Fiscal Standard
06/15/16 06:31 PMHC Trending Hot Stocks: Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), StemCells Inc (NASDAQ:STEM) - share market updates (press release)
06/13/16 09:37 AMHC Stocks Overview: Chimerix Inc (NASDAQ:CMRX), StemCells Inc (NASDAQ:STEM) - share market updates (press release)
06/10/16 06:59 PMHC Stocks Impression: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), StemCells Inc (NASDAQ:STEM) - share market updates (press release)
06/09/16 09:40 AMUpdated Trading Report: ImmunoGen, Inc. (NASDAQ:IMGN) , StemCells, Inc. (NASDAQ:STEM) - Street Updates
06/08/16 09:44 AMHC Stocks Focal Point: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), StemCells Inc (NASDAQ:STEM) - share market updates (press release)
06/08/16 09:44 AMStocks within Traders Screening: StemCells, Inc. (NASDAQ:STEM) , Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) - Street Updates
06/07/16 06:54 PMEarnings Overview of the Stocks: Liberty Broadband Corporation (NASDAQ:LBRDK), StemCells Inc. (NASDAQ:STEM) - Beacon Chronicle
06/07/16 09:24 AMMaxim Group Downgrades StemCells Inc to Hold - Trade Calls
06/03/16 07:16 PMEarnings Stocks Analysis: StemCells Inc. (NASDAQ:STEM), Towerstream Corporation (NASDAQ:TWER) - Beacon Chronicle
06/03/16 07:16 PMMid-day Market Update: StemCells Inc (NASDAQ:STEM) - The Point Review

Social

About StemCells

StemCells logoStemCells, Inc. is engaged in the research, development, and commercialization of stem cell therapeutics. The Company is focused on developing and commercializing stem and progenitor cells as the basis for therapeutics and therapies. The Company's lead product development program is its CNS Program, in which it is developing applications for HuCNS-SC cells, its human neural platform technology. It is in clinical development with its HuCNS-SC cells for a range of diseases and disorders of the central nervous system. The CNS consists of the brain, spinal cord and eye, and it is stem cell company in clinical development for indications in all three compartments comprising the CNS, which include with respect to the brain, with respect to the spinal cord and with respect to the eye. The Phase I clinical trial was completed in Pelizeaus-Merzbacher Disease, Neuronal Ceroid Lipofuscinosis and Phase I/II clinical trial in multiple sites for chronic spinal cord injury was completed.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: STEM
  • CUSIP:
Key Metrics:
  • Previous Close: $0.36
  • 50 Day Moving Average: $0.41
  • 200 Day Moving Average: $2.71
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $4.21M
  • Beta: 0.97
Additional Links:
StemCells (NASDAQ:STEM) Chart for Monday, July, 25, 2016